[Ureidosuccinate of 5(4)amino-4(5)imidazolecarboxamide: biopsy study after "controlled" use of the new substance in hepatic therapy].
D000328:Adult; D000368:Aged; D000620:Aminoimidazole Carboxamide / Q000031:analogs & derivatives / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D008107:Liver Diseases / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D013386:Succinates / Q000627:therapeutic use
D007093:Imidazoles; D013386:Succinates; D000620:Aminoimidazole Carboxamide
L'ureidosuccinato di 5(4)amino-4(5)imidazolcarbossiamide: risultanze bioptiche dopo impiego "controllato" della nuova sostanza in terapia epatica.